基托/γ-多聚胺酸基皮克林乳液凝:一个有前途的透皮载体的克罗塞丁
Yicheng Yang1, Qinan Huang1, Lipei Miao1
1Laboratory of Pharmaceutical Engineering of Zhejiang Province, Key Laboratory for Green Pharmaceutical Technologies and Related Equipment of Ministry of Education, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, PR China.
International journal of biological macromolecules
|May 14, 2025
概括
这项研究开发了一种新型的通过皮肤的载体,使用奇托和 γ-多聚胺酸纳米颗粒来改善克罗西的输送. 由此产生的皮克林乳液凝增强了克罗塞丁的作用.
科学领域:
- 生物材料科学 生物材料科学
- 药物输送系统 药物输送系统
- 纳米技术 纳米技术
背景情况:
- 克罗西 (CT) 是一种有价值的天然化合物,具有不良的溶解性,低生物可用性和不稳定性,阻碍了其治疗用途.
- 开发有效的输送系统对于克服这些局限性和利用CT的药用潜力至关重要.
研究的目的:
- 开发一种新的皮克林乳液凝 (CT-PE),使用奇托 (CS) 和γ-多聚胺酸 (γ-PGA) 纳米颗粒作为克罗西的透皮载体.
- 为了评估CT的物理化学特性,稳定性和体外通过皮肤释放的CT从开发的载体.
- 评估CT-PE系统的抗氧化,抗微生物和细胞毒性作用.
主要方法:
- 通过静电交联和机械球磨机合成CS/γ-PGA纳米粒子.
- 使用玉米薄荷油作为油阶段,制定了一个CT-装载的皮克林乳液凝 (CT-PE).
- 描述CT-PE的风湿性质,稳定性,体外释放,抗氧化和抗菌活性以及细胞毒性.
主要成果:
- 在CT-PE中实现了CT的高封装效率 (98.53%).
- CT-PE证明了增强的风湿性质,储存稳定性和持续的,向的体外透皮释放.
- 呈现出强大的抗氧化和抗微生物活性,没有观察到细胞毒性.
结论:
- CS/γ-PGA纳米颗粒稳定皮克林乳液凝是一种有前途的生物相容性和高效的透皮载体.
- 这种系统显著提高了CT的治疗效果,为皮肤病治疗和药物输送提供了潜力.
- CS和γ-PGA之间的协同相互作用有助于载体的稳定性和有效性.
更多相关视频
相关概念视频
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Transdermal Drug Delivery Systems
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...


